280 related articles for article (PubMed ID: 23179790)
1. Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors.
Liu WH; You N; Zhang N; Yan HT; Wang T; Huang Z; Liu HB; Tang LJ
Cell Oncol (Dordr); 2012 Dec; 35(6):397-409. PubMed ID: 23179790
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxia.
Marie-Egyptienne DT; Lohse I; Hill RP
Cancer Lett; 2013 Nov; 341(1):63-72. PubMed ID: 23200673
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
4. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.
Liu X; Fan D
Curr Pharm Des; 2015; 21(10):1279-91. PubMed ID: 25506898
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor microenvironment on cancer stem cell fate in solid tumors.
Razi S; Haghparast A; Chodari Khameneh S; Ebrahimi Sadrabadi A; Aziziyan F; Bakhtiyari M; Nabi-Afjadi M; Tarhriz V; Jalili A; Zalpoor H
Cell Commun Signal; 2023 Jun; 21(1):143. PubMed ID: 37328876
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
7. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
Yoshida GJ; Saya H
Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells: problems for therapy?
Alison MR; Lim SM; Nicholson LJ
J Pathol; 2011 Jan; 223(2):147-61. PubMed ID: 21125672
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
Ye X; Weinberg RA
Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
[TBL] [Abstract][Full Text] [Related]
11. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
12. Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.
Jin W
Cells; 2020 Jan; 9(1):. PubMed ID: 31952344
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells and their potential implications for the treatment of solid tumors.
Grotenhuis BA; Wijnhoven BP; van Lanschot JJ
J Surg Oncol; 2012 Aug; 106(2):209-15. PubMed ID: 22371125
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
Topcul M; Cetin I
J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
[TBL] [Abstract][Full Text] [Related]
15. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.
Biddle A; Liang X; Gammon L; Fazil B; Harper LJ; Emich H; Costea DE; Mackenzie IC
Cancer Res; 2011 Aug; 71(15):5317-26. PubMed ID: 21685475
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Cancer Stem Cell Isolation and Characterization.
Jariyal H; Gupta C; Bhat VS; Wagh JR; Srivastava A
Stem Cell Rev Rep; 2019 Dec; 15(6):755-773. PubMed ID: 31863337
[TBL] [Abstract][Full Text] [Related]
19. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.
Najafi M; Farhood B; Mortezaee K; Kharazinejad E; Majidpoor J; Ahadi R
J Cancer Res Clin Oncol; 2020 Jan; 146(1):19-31. PubMed ID: 31734836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]